<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01004107</url>
  </required_header>
  <id_info>
    <org_study_id>P0508332</org_study_id>
    <nct_id>NCT01004107</nct_id>
  </id_info>
  <brief_title>Evaluation of Radiesse® Dermal Filler for Hand Rejuvenation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merz North America, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merz North America, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and effectiveness of Radiesse® Injectable
      Dermal Filler for hand treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the safety of Radiesse® Injectable Dermal Filler for hand treatment using a 5-point ordinal rating scale</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Aging Hands</condition>
  <arm_group>
    <arm_group_label>Radiesse® Injectable Dermal Filler</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device: Radiesse® Injectable Dermal Filler</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed Treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Cross over to treatment with Radiesse® Injectable Dermal Filler at 3 Months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Radiesse® Injectable Dermal Filler</intervention_name>
    <description>Calcium hydroxylapatite particles suspended in an aqueous based gel carrier</description>
    <arm_group_label>Radiesse® Injectable Dermal Filler</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Has right and left hands with a rating of 3 or 4 on the BHVSS as determined by the
             treating physician

          -  Is at least 18 years of age

          -  Signs a written informed consent

          -  Understands and accepts the obligation not to receive any other procedures in the
             dorsum of the hands through 12 month follow up

          -  Understands and accepts the obligation and is logistically able to present for all
             scheduled follow-up visits

        Exclusion Criteria

          -  Has planned activities during study that could interfere with treatment (i.e., boxing)
             or that impose significant force to the hands.

          -  Has history of hypertropic scarring.

          -  Has a known bleeding disorder (e.g., thrombocytopenia, thrombasthenia, or von
             Willebrand's disease).

          -  Has received or is anticipated to receive antiplatelets, anticoagulants, thrombolytics
             , vitamin E or anti-inflammatories within 2 weeks pre treatment.

          -  Is receiving systemic corticosteroids or anabolic steroids (standard doses of inhaled
             or nasal corticosteroids are acceptable).

          -  Has a history of chronic or recurrent infection (e.g., Pseudomona paronychia) or
             inflammation (e.g., rheumatoid arthritis) that would preclude participation in the
             study.

          -  Has a known hypersensitivity to any of the components of Radiesse or local anesthesia.

          -  Has received the following in the dorsum of the hand within 4 weeks of treatment or
             intends to receive these products and or treatments during the study: Over the-counter
             wrinkle products (e.g., alpha-hydroxy acids) or prescription treatments (e.g., Renova,
             Retin-A, micro-dermabrasion, chemical peels)

          -  Has had any dermal fillers or surgery in the dorsum of the hand.

          -  Is a female of child bearing potential and not using medically effective birth control
             or is pregnant or lactating.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Busso M,et al. Multi-center Randomized Trial Assessing the Effectiveness and Safety of Calcium Hydroxlapatite For Hand Rejuvenation. Derm Surg 2010; 36:790-797</citation>
  </reference>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2009</study_first_submitted>
  <study_first_submitted_qc>October 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2009</study_first_posted>
  <disposition_first_submitted>April 20, 2012</disposition_first_submitted>
  <disposition_first_submitted_qc>April 23, 2012</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">April 25, 2012</disposition_first_posted>
  <last_update_submitted>June 17, 2014</last_update_submitted>
  <last_update_submitted_qc>June 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <pending_results>
    <submitted>October 6, 2016</submitted>
    <returned>November 29, 2016</returned>
    <submitted>January 26, 2017</submitted>
    <returned>March 16, 2017</returned>
    <submitted>September 18, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

